Literature DB >> 18319102

The diagnosis and management of cardiovascular disease in cancer patients.

Syed Wamique Yusuf1, Peter Razeghi, Edward T H Yeh.   

Abstract

Cardiovascular disease is commonly found in cancer patients. The co-existence of heart disease and cancer in a patient often complicates treatment, because therapy for one disease may negatively affect the outcome of the other disease. In addition, guidelines for the treatment of cardiovascular disease are often based on studies, which exclude patients who have cancer. In this review we will discuss the diagnosis and management of cardiovascular disease in cancer patients. We will focus on cancer-related causes of cardiovascular disease and special treatment options for cardiovascular disease in cancer patients. The cardiac complications of cancer therapy will be discussed according to common syndromes: left ventricular dysfunction, myocardial ischemia, blood pressure changes, thromboembolism, bradyarrhythmias, and prolonged QT interval.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18319102     DOI: 10.1016/j.cpcardiol.2008.01.002

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


  15 in total

1.  Cardiac QTc interval characteristics before and after hematopoietic stem cell transplantation: an analysis of 995 consecutive patients at a single center.

Authors:  W P Miller; R Shanley; P Dorostkar
Journal:  Bone Marrow Transplant       Date:  2015-03-30       Impact factor: 5.483

Review 2.  Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis.

Authors:  Saamir A Hassan; Nicolas Palaskas; Peter Kim; Cezar Iliescu; Juan Lopez-Mattei; Elie Mouhayar; Rohit Mougdil; Kara Thompson; Jose Banchs; Syed Wamique Yusuf
Journal:  Curr Atheroscler Rep       Date:  2018-02-08       Impact factor: 5.113

Review 3.  Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.

Authors:  Hui-Ming Chang; Tochukwu M Okwuosa; Tiziano Scarabelli; Rohit Moudgil; Edward T H Yeh
Journal:  J Am Coll Cardiol       Date:  2017-11-14       Impact factor: 24.094

Review 4.  Venous thromboembolism and cancer: a systematic review.

Authors:  Celso Arrais Rodrigues; Renata Ferrarotto; Roberto Kalil Filho; Yana A S Novis; Paulo M G Hoff
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

5.  Therapeutic potential of c-Myc inhibition in the treatment of hypertrophic cardiomyopathy.

Authors:  Julie A Wolfram; Edward J Lesnefsky; Brian D Hoit; Mark A Smith; Hyoung-Gon Lee
Journal:  Ther Adv Chronic Dis       Date:  2011-03-01       Impact factor: 5.091

Review 6.  Cancer chemotherapy and cardiac arrhythmias: a review.

Authors:  Juan Tamargo; Ricardo Caballero; Eva Delpón
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

7.  Nonadherence to Statins and Antihypertensives and Hospitalizations Among Elderly Medicare Beneficiaries With Incident Cancer.

Authors:  Ishveen Chopra; Nilanjana Dwibedi; Malcolm D Mattes; Xi Tan; Patricia Findley; Usha Sambamoorthi
Journal:  J Natl Compr Canc Netw       Date:  2017-11       Impact factor: 11.908

Review 8.  Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents.

Authors:  C P Escalante; Y C Chang; K Liao; T Rouleau; J Halm; P Bossi; S Bhadriraju; N Brito-Dellan; S Sahai; S W Yusuf; A Zalpour; L S Elting
Journal:  Support Care Cancer       Date:  2016-06-25       Impact factor: 3.603

9.  The role of patient-clinician information engagement and information seeking from nonmedical channels in fruit and vegetable intake among cancer patients.

Authors:  Mihaela Moldovan-Johnson; Lourdes Martinez; Nehama Lewis; Derek Freres; Robert C Hornik
Journal:  J Health Commun       Date:  2014-05-29

Review 10.  Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.

Authors:  Jawed A Siddiqui; Ramesh Pothuraju; Maneesh Jain; Surinder K Batra; Mohd W Nasser
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-03-25       Impact factor: 10.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.